Improved glucose tolerance after initiation of Elexacaftor / Tezacaftor / Ivacaftor in adults with cystic fibrosis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Improved glucose tolerance after initiation of Elexacaftor / Tezacaftor / Ivacaftor in adults with cystic fibrosis
Authors
Keywords
-
Journal
Journal of Cystic Fibrosis
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-01-20
DOI
10.1016/j.jcf.2023.01.004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New Concepts in the Pathogenesis of Cystic Fibrosis–Related Diabetes
- (2022) Amir Moheet et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Short-Term Effects of Elexacaftor/Tezacaftor/Ivacaftor Combination on Glucose Tolerance in Young People With Cystic Fibrosis—An Observational Pilot Study
- (2022) Insa Korten et al. Frontiers in Pediatrics
- Lumacaftor/ivacaftor in cystic fibrosis: effects on glucose metabolism and insulin secretion
- (2021) C. Colombo et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Effect of elexacaftor-tezacaftor-ivacaftor on body weight and metabolic parameters in adults with cystic fibrosis
- (2021) Max C. Petersen et al. Journal of Cystic Fibrosis
- Effect of one-year lumacaftor–ivacaftor treatment on glucose tolerance abnormalities in cystic fibrosis patients
- (2020) Bastien Misgault et al. Journal of Cystic Fibrosis
- Lumacaftor/ivacaftor therapy fails to increase insulin secretion in F508del/F508del CF patients
- (2020) Amir Moheet et al. Journal of Cystic Fibrosis
- Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries
- (2019) Nataliya Volkova et al. Journal of Cystic Fibrosis
- Cystic fibrosis related diabetes in Europe: Prevalence, risk factors and outcome; Olesen et al
- (2019) Hanne V Olesen et al. Journal of Cystic Fibrosis
- Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial
- (2019) Harry G M Heijerman et al. LANCET
- Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
- (2019) Peter G. Middleton et al. NEW ENGLAND JOURNAL OF MEDICINE
- ISPAD Clinical Practice Consensus Guidelines 2018 Compendium Management of cystic fibrosis related diabetes in children and adolescents
- (2018) Antoinette Moran et al. PEDIATRIC DIABETES
- CFTR Influences Beta Cell Function and Insulin Secretion Through Non-Cell Autonomous Exocrine-Derived Factors
- (2017) Xingshen Sun et al. ENDOCRINOLOGY
- Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del
- (2017) Jennifer L. Taylor-Cousar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Variation of glucose tolerance in adult patients with cystic fibrosis: What is the potential contribution of insulin sensitivity?
- (2016) Valérie Boudreau et al. Journal of Cystic Fibrosis
- Characterization of patients with cystic fibrosis presenting an indeterminate glucose tolerance (INDET)
- (2016) Adèle Coriati et al. Journal of Cystic Fibrosis
- Effects of Ivacaftor in Patients With Cystic Fibrosis Who Carry the G551D Mutation and Have Severe Lung Disease
- (2014) Peter J. Barry et al. CHEST
- High Variability in Oral Glucose Tolerance among 1,128 Patients with Cystic Fibrosis: A Multicenter Screening Study
- (2014) Nicole Scheuing et al. PLoS One
- Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study
- (2013) Melena D Bellin et al. PEDIATRIC DIABETES
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutation
- (2011) Bonnie W. Ramsey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Glucose Abnormalities in Cystic Fibrosis Are Preceded by Poor Weight Gain
- (2009) S. Hameed et al. DIABETES CARE
- Oxidative stress and cystic fibrosis-related diabetes: A pilot study in children
- (2008) Thierry Ntimbane et al. Journal of Cystic Fibrosis
- Glucose Tolerance and Insulin Secretion, Morbidity, and Death in Patients with Cystic Fibrosis
- (2007) Elise Bismuth et al. JOURNAL OF PEDIATRICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started